UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7823) 7823
Newspaper Article (1384) 1384
Book Chapter (94) 94
Magazine Article (51) 51
Book / eBook (5) 5
Trade Publication Article (3) 3
Dissertation (2) 2
Web Resource (2) 2
Publication (1) 1
Reference (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6009) 6009
dyspnea (5265) 5265
science & technology (4833) 4833
life sciences & biomedicine (4677) 4677
male (3641) 3641
female (3517) 3517
middle aged (2709) 2709
dyspnea - etiology (2428) 2428
patients (2339) 2339
aged (2234) 2234
adult (1894) 1894
respiratory system (1367) 1367
general & internal medicine (1267) 1267
biological and medical sciences (1235) 1235
medical sciences (1226) 1226
abridged index medicus (1184) 1184
treatment outcome (1145) 1145
dyspnea - drug therapy (1117) 1117
respiration (1037) 1037
clinical trials (945) 945
medicine, general & internal (939) 939
drug dosages (935) 935
care and treatment (910) 910
chronic obstructive pulmonary disease (897) 897
pneumonia (893) 893
mortality (818) 818
quality of life (808) 808
heart failure (795) 795
pain (792) 792
lung diseases (759) 759
oncology (751) 751
cardiovascular system & cardiology (736) 736
cardiac & cardiovascular systems (709) 709
edema (663) 663
aged, 80 and over (651) 651
dyspnea - physiopathology (643) 643
risk factors (641) 641
diagnosis, differential (636) 636
diagnosis (610) 610
infections (604) 604
drug therapy (602) 602
chemotherapy (585) 585
dyspnea - diagnosis (564) 564
research (564) 564
hospitals (550) 550
medicine (547) 547
asthma (536) 536
cancer therapies (523) 523
hypertension (517) 517
laboratories (513) 513
studies (494) 494
pneumology (485) 485
diarrhea (481) 481
health aspects (468) 468
medical research (466) 466
severity of illness index (466) 466
case report (464) 464
cancer (455) 455
metastasis (451) 451
tomography, x-ray computed (451) 451
analysis (447) 447
dyspnea - chemically induced (445) 445
anemia (441) 441
lung diseases, obstructive (438) 438
adolescent (434) 434
pulmonary disease, chronic obstructive - drug therapy (434) 434
fda approval (429) 429
prognosis (426) 426
biopsy (418) 418
electrocardiography (414) 414
respiratory tract diseases (413) 413
fever (410) 410
cardiovascular disease (403) 403
pulmonary disease, chronic obstructive - physiopathology (402) 402
heart (396) 396
lungs (395) 395
dyspnea - therapy (388) 388
palliative care (388) 388
retrospective studies (381) 381
respiratory function tests (373) 373
pediatrics (372) 372
internal medicine (369) 369
double-blind method (366) 366
cough (356) 356
pharmacology. drug treatments (355) 355
lung cancer (354) 354
time factors (353) 353
prospective studies (349) 349
medical prognosis (343) 343
medical imaging (333) 333
blood pressure (332) 332
constipation (330) 330
acute disease (327) 327
covid-19 (323) 323
family medical history (323) 323
bronchodilator agents - therapeutic use (322) 322
tumors (317) 317
pulmonary arteries (316) 316
critical care medicine (315) 315
disease progression (307) 307
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8764) 8764
German (220) 220
French (189) 189
Spanish (74) 74
Japanese (44) 44
Italian (39) 39
Russian (25) 25
Dutch (24) 24
Chinese (21) 21
Portuguese (21) 21
Polish (20) 20
Romanian (11) 11
Danish (7) 7
Finnish (5) 5
Hebrew (5) 5
Czech (4) 4
Hungarian (4) 4
Swedish (3) 3
Norwegian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 18, pp. 1671 - 1680
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Hospitalization - statistics & numerical data | Male | Dyspnea - etiology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Adrenergic beta-Agonists - administration & dosage | Adult | Female | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Pulmonary Disease, Chronic Obstructive - complications | Muscarinic Antagonists - administration & dosage | Androstadienes - administration & dosage | Intention to Treat Analysis | Quality of Life | Dyspnea - drug therapy | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Treatment outcome | Lung diseases, Obstructive | Care and treatment | Usage | Analysis | Diagnosis | Inhalers | Pneumonia | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Critical care | Fluticasone | Patients | Quality of life | Medicine | Hospitals | Obstructive lung disease | Population | Chronic obstructive pulmonary disease | Drug dosages | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Journal of medical virology, ISSN 0146-6615, 07/2020, Volume 92, Issue 7, pp. 797 - 806
northeast Chongqing | treatment | cognition | COVID‐19 | clinical features | Life Sciences & Biomedicine | Science & Technology | Virology | Betacoronavirus - pathogenicity | Diabetes Mellitus - pathology | Cough - physiopathology | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Male | Tomography, X-Ray Computed | Interferons - therapeutic use | Neoplasms - diagnosis | Adrenal Cortex Hormones - therapeutic use | Fever - physiopathology | COVID-19 | Cardiovascular Diseases - complications | SARS-CoV-2 | Ritonavir - therapeutic use | Cardiovascular Diseases - diagnosis | Betacoronavirus - isolation & purification | Antiviral Agents - therapeutic use | Diabetes Mellitus - drug therapy | Diabetes Complications - drug therapy | Fatigue - diagnosis | Biomarkers - blood | Diabetes Complications - blood | Fever - virology | Neoplasms - drug therapy | Adolescent | Coronavirus Infections - pathology | Fatigue - physiopathology | Fatigue - virology | Pneumonia, Viral - diagnosis | Pandemics | COVID-19 Testing | Cardiovascular Diseases - drug therapy | Cough - diagnosis | Cardiovascular Diseases - pathology | Anti-Bacterial Agents - therapeutic use | Neoplasms - complications | China | Pneumonia, Viral - complications | Coronavirus Infections - complications | Adult | Female | Retrospective Studies | Diabetes Mellitus - diagnosis | Drugs, Chinese Herbal - therapeutic use | Severity of Illness Index | Cough - virology | Coronavirus Infections - diagnosis | Pneumonia, Viral - pathology | Fever - diagnosis | Clinical Laboratory Techniques - methods | Lopinavir - therapeutic use | Aged | Neoplasms - pathology | Drug Combinations | Corticoids | Therapy | Anorexia | Health services | Viral diseases | Malignancy | Gender | Epidemiology | Antiinfectives and antibacterials | Chinese medicine | Dyspnea | Computed tomography | Lymphocytes | Opacity | Public health | Hypertension | Signs and symptoms | Corticosteroids | Complications | Diabetes mellitus | Health risks | Traditional Chinese medicine | Fatigue | Lactate dehydrogenase | Myalgia | Coronaviruses | Patients | Fever | Cough | L-Lactate dehydrogenase | Herbal medicine | Infectious diseases | Respiratory distress syndrome | Cell number | Secondary infection | Interferon | Aspartate aminotransferase | Plasma levels | Dimers | Lactic acid | Cardiovascular diseases | Respiration | Index Medicus
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 12/2015, Volume 22, Issue 6, pp. 877 - 887
Adverse events | Targeted therapy | Tyrosine kinase inhibitor | Sorafenib | Differentiated thyroid cancer | Oncology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Adenoma, Oxyphilic - enzymology | Dyspnea - chemically induced | Thyroid Neoplasms - enzymology | Prevalence | Adenocarcinoma, Follicular - radiotherapy | Humans | Middle Aged | Drug Resistance, Neoplasm | Hypertension - drug therapy | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Protein Kinase Inhibitors - adverse effects | Weight Loss - drug effects | Incidence | Neoplasms, Second Primary - chemically induced | Adenocarcinoma, Follicular - drug therapy | Adenoma, Oxyphilic - drug therapy | Hypocalcemia - epidemiology | Niacinamide - adverse effects | Carcinoma, Papillary - drug therapy | Niacinamide - therapeutic use | Thyroid Neoplasms - radiotherapy | Adenocarcinoma, Follicular - enzymology | Neoplasms, Second Primary - epidemiology | Niacinamide - analogs & derivatives | Diarrhea - epidemiology | Diarrhea - chemically induced | Iodine Radioisotopes - therapeutic use | Hypocalcemia - chemically induced | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Hypertension - chemically induced | Female | Carcinoma, Papillary - enzymology | Hypertension - epidemiology | Adenoma, Oxyphilic - radiotherapy | Drug Eruptions - etiology | Phenylurea Compounds - therapeutic use | Dyspnea - epidemiology | Disease-Free Survival | Carcinoma, Papillary - radiotherapy | Fatigue - epidemiology | Thyroid Neoplasms - drug therapy | Protein Kinase Inhibitors - therapeutic use | Aged | Diarrhea - drug therapy | Drug Eruptions - epidemiology | Radiopharmaceuticals - therapeutic use | Index Medicus | targeted therapy | Research | tyrosine kinase inhibitor | adverse events | sorafenib | differentiated thyroid cancer
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Tumors | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 1, pp. 32 - 43
RANDOMIZED CONTROLLED TRIAL | POPULATION | HOSPITALIZED-PATIENTS | RISK | NATIONAL REGISTRY ADHERE | OUTCOMES | DIURETICS | UMCG Approved | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Heart Failure - complications | Natriuretic Peptide, Brain - therapeutic use | Recurrence | Acute Disease | Natriuretic Agents - adverse effects | Double-Blind Method | Humans | Middle Aged | Male | Dyspnea - etiology | Hypotension - chemically induced | Natriuretic Peptide, Brain - adverse effects | Heart Failure - drug therapy | Intention to Treat Analysis | Dyspnea - drug therapy | Female | Aged | Kidney Diseases - etiology | Patient Readmission - statistics & numerical data | Natriuretic Agents - therapeutic use | Heart Failure - mortality | Heart failure | Drug therapy | Shortness of breath | Edema | Renal function | Toxicity | Research & development--R&D | Hypotension | Glomerular filtration rate | Studies | Heart rate | Dyspnea | Databases | Death | Respiration | Research centers | Heart diseases | Drug dosages | Index Medicus | Abridged Index Medicus | Heart Failure/complications/drug therapy/mortality | Natriuretic Agents/adverse effects/therapeutic use | MEDICIN OCH HÄLSOVETENSKAP | Dyspnea/drug therapy/etiology | Brain/adverse effects/therapeutic use | Hypotension/chemically induced | Kidney Diseases/etiology | Patient Readmission/statistics & numerical data | Natriuretic Peptide | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article